Efficacy and safety of co administered once weekly cagrilintide 24 mg with once weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double blind, active controlled, phase 2 trial The Lancet CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 Hypertension Cagrilintide, Semaglutide (Blend) Liberty Peptides Type 2 diabetes: Combo of semaglutide and cagrilintide reduces blood sugar and leads to weight loss Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine